PubMed:2033090
Annnotations
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 313-318 | HP_0002664 | denotes | tumor |
| T2 | 492-501 | HP_0002665 | denotes | lymphomas |
| T3 | 550-555 | HP_0002664 | denotes | tumor |
| T4 | 666-675 | HP_0002665 | denotes | lymphomas |
| T5 | 774-782 | HP_0002664 | denotes | tumorous |
| T6 | 974-979 | HP_0002664 | denotes | tumor |
| T7 | 1032-1049 | HP_0002202 | denotes | Pleural effusions |
| T8 | 1072-1085 | HP_0003002 | denotes | breast cancer |
| T9 | 1072-1085 | HP_0100013 | denotes | breast cancer |
| T10 | 1079-1085 | HP_0002664 | denotes | cancer |
| T11 | 1270-1275 | HP_0002664 | denotes | tumor |
| T12 | 1413-1418 | HP_0002664 | denotes | tumor |
| T13 | 1461-1466 | HP_0002664 | denotes | tumor |
| T14 | 1482-1499 | HP_0002202 | denotes | pleural effusions |
| T15 | 1693-1699 | HP_0002664 | denotes | cancer |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 17-52 | protein | denotes | estrogen and progesterone receptors |
| T2 | 64-88 | protein | denotes | Ki-67 and p-145 antigens |
| T3 | 92-110 | cell_type | denotes | single tumor cells |
| T4 | 224-232 | protein | denotes | antigens |
| T5 | 263-289 | cell_type | denotes | isolated white blood cells |
| T6 | 306-324 | cell_type | denotes | single tumor cells |
| T7 | 379-384 | protein | denotes | Ki-67 |
| T8 | 389-399 | protein | denotes | anti-p-145 |
| T9 | 550-561 | cell_type | denotes | tumor cells |
| T10 | 740-764 | cell_type | denotes | normal mesothelial cells |
| T11 | 815-823 | protein | denotes | estrogen |
| T12 | 828-850 | protein | denotes | progesterone receptors |
| T13 | 852-854 | protein | denotes | ER |
| T14 | 859-861 | protein | denotes | PR |
| T15 | 974-985 | cell_type | denotes | tumor cells |
| T16 | 1099-1101 | protein | denotes | ER |
| T17 | 1125-1127 | protein | denotes | PR |
| T18 | 1213-1215 | protein | denotes | ER |
| T19 | 1220-1222 | protein | denotes | PR |
| T20 | 1237-1254 | protein | denotes | hormone receptors |
| T21 | 1294-1296 | protein | denotes | ER |
| T22 | 1306-1308 | protein | denotes | PR |
| T23 | 1461-1472 | cell_type | denotes | tumor cells |
| T24 | 1550-1575 | protein | denotes | hormone receptor proteins |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-164 | Sentence | denotes | Demonstration of estrogen and progesterone receptors as well as Ki-67 and p-145 antigens in single tumor cells from blood and pleural effusions using a slide assay. |
| S2 | 165-358 | Sentence | denotes | We describe a slide assay that allows the demonstration of antigens localized in the nucleus from isolated white blood cells as well as from single tumor cells derived from malignant effusions. |
| S3 | 359-502 | Sentence | denotes | With the antibodies Ki-67 and anti-p-145 an increased rate of nuclear and nucleolar staining resulted in cells from highly malignant lymphomas. |
| S4 | 503-599 | Sentence | denotes | An almost identical reaction was obtained when tumor cells from malignant effusions were tested. |
| S5 | 600-797 | Sentence | denotes | Cells isolated from the blood of patients with leukemic spread of lymphomas of low malignancy yielded a weak staining comparable to that of normal mesothelial cells from non-tumorous cavity fluids. |
| S6 | 798-927 | Sentence | denotes | The detection of estrogen and progesterone receptors (ER and PR) localized in the cell nucleus can be achieved by the same assay. |
| S7 | 928-1031 | Sentence | denotes | The reaction is enhanced by incubation of the tumor cells for 30 min at 37 degrees C prior to fixation. |
| S8 | 1032-1098 | Sentence | denotes | Pleural effusions from 20 patients with breast cancer were tested. |
| S9 | 1099-1165 | Sentence | denotes | ER was positive in 13 and PR was positive in 12 of the 20 samples. |
| S10 | 1166-1232 | Sentence | denotes | In 5 cases there was a divergent reaction with ER and PR antibody. |
| S11 | 1233-1333 | Sentence | denotes | The hormone receptors of the primary tumor were known in 15 (ER) and 14 (PR) patients, respectively. |
| S12 | 1334-1500 | Sentence | denotes | In each cohort there was only one case with a negative reaction of the primary tumor and a positive reaction with the isolated tumor cells from the pleural effusions. |
| S13 | 1501-1700 | Sentence | denotes | These results indicate that the demonstration of hormone receptor proteins in cells from malignant effusions is possible and that there is a correlation with the status of the primary site of cancer. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 17-52 | NP | denotes | estrogen and progesterone receptors |
| C2 | 64-88 | NP | denotes | Ki-67 and p-145 antigens |
| C3 | 92-110 | NP | denotes | single tumor cells |
| C4 | 126-143 | NP | denotes | pleural effusions |
| C5 | 150-163 | NP | denotes | a slide assay |
| C6 | 177-190 | NP | denotes | a slide assay |
| C7 | 191-195 | NP | denotes | that |
| C8 | 306-324 | NP | denotes | single tumor cells |
| C9 | 338-357 | NP | denotes | malignant effusions |
| C10 | 364-399 | NP | denotes | the antibodies Ki-67 and anti-p-145 |
| C12 | 567-586 | NP | denotes | malignant effusions |
| C11 | 550-586 | NP | denotes | tumor cells from malignant effusions |
| C13 | 702-717 | NP | denotes | a weak staining |
| C14 | 732-736 | NP | denotes | that |
| C16 | 852-854 | NP | denotes | ER |
| C17 | 859-861 | NP | denotes | PR |
| C15 | 815-862 | NP | denotes | estrogen and progesterone receptors (ER and PR) |
| C18 | 912-926 | NP | denotes | the same assay |
| C19 | 970-985 | NP | denotes | the tumor cells |
| C20 | 1032-1049 | NP | denotes | Pleural effusions |
| C21 | 1099-1101 | NP | denotes | ER |
| C22 | 1125-1127 | NP | denotes | PR |
| C23 | 1213-1215 | NP | denotes | ER |
| C24 | 1220-1222 | NP | denotes | PR |
| C25 | 1258-1275 | NP | denotes | the primary tumor |
| C26 | 1293-1297 | NP | denotes | (ER) |
| C27 | 1305-1309 | NP | denotes | (PR) |
| C28 | 1401-1418 | NP | denotes | the primary tumor |
| C29 | 1448-1472 | NP | denotes | the isolated tumor cells |
| C30 | 1478-1499 | NP | denotes | the pleural effusions |
| C31 | 1590-1609 | NP | denotes | malignant effusions |
| R1 | C6 | C5 | coref-ident | a slide assay,a slide assay |
| R2 | C7 | C6 | coref-relat | that,a slide assay |
| R3 | C8 | C3 | coref-ident | single tumor cells,single tumor cells |
| R4 | C10 | C2 | coref-ident | the antibodies Ki-67 and anti-p-145,Ki-67 and p-145 antigens |
| R5 | C12 | C9 | coref-ident | malignant effusions,malignant effusions |
| R6 | C14 | C13 | coref-pron | that,a weak staining |
| R7 | C16 | C15 | coref-other | ER,estrogen and progesterone receptors (ER and PR) |
| R8 | C17 | C15 | coref-other | PR,estrogen and progesterone receptors (ER and PR) |
| R9 | C15 | C1 | coref-ident | estrogen and progesterone receptors (ER and PR),estrogen and progesterone receptors |
| R10 | C18 | C6 | coref-ident | the same assay,a slide assay |
| R11 | C19 | C11 | coref-ident | the tumor cells,tumor cells from malignant effusions |
| R12 | C20 | C4 | coref-ident | Pleural effusions,pleural effusions |
| R13 | C21 | C16 | coref-ident | ER,ER |
| R14 | C22 | C17 | coref-ident | PR,PR |
| R15 | C23 | C21 | coref-ident | ER,ER |
| R16 | C24 | C22 | coref-ident | PR,PR |
| R17 | C26 | C23 | coref-ident | (ER),ER |
| R18 | C27 | C24 | coref-ident | (PR),PR |
| R19 | C28 | C25 | coref-ident | the primary tumor,the primary tumor |
| R20 | C29 | C19 | coref-ident | the isolated tumor cells,the tumor cells |
| R21 | C30 | C20 | coref-ident | the pleural effusions,Pleural effusions |
| R22 | C31 | C12 | coref-ident | malignant effusions,malignant effusions |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 92-110 | cell_type | denotes | single tumor cells |
| T2 | 152-163 | other_name | denotes | slide assay |
| T3 | 224-232 | protein_family_or_group | denotes | antigens |
| T4 | 250-257 | cell_component | denotes | nucleus |
| T5 | 263-289 | cell_type | denotes | isolated white blood cells |
| T6 | 306-324 | cell_type | denotes | single tumor cells |
| T7 | 338-357 | other_name | denotes | malignant effusions |
| T8 | 379-384 | protein_molecule | denotes | Ki-67 |
| T9 | 389-399 | protein_molecule | denotes | anti-p-145 |
| T10 | 421-428 | other_name | denotes | nuclear |
| T11 | 433-451 | other_name | denotes | nucleolar staining |
| T12 | 475-501 | tissue | denotes | highly malignant lymphomas |
| T13 | 550-561 | cell_type | denotes | tumor cells |
| T14 | 567-586 | other_name | denotes | malignant effusions |
| T15 | 624-629 | tissue | denotes | blood |
| T16 | 633-641 | multi_cell | denotes | patients |
| T17 | 647-662 | other_name | denotes | leukemic spread |
| T18 | 666-675 | tissue | denotes | lymphomas |
| T19 | 679-693 | other_name | denotes | low malignancy |
| T20 | 740-764 | cell_type | denotes | normal mesothelial cells |
| T21 | 770-796 | tissue | denotes | non-tumorous cavity fluids |
| T22 | 815-823 | protein_family_or_group | denotes | estrogen |
| T23 | 828-840 | lipid | denotes | progesterone |
| T24 | 852-854 | protein_family_or_group | denotes | ER |
| T25 | 859-861 | protein_family_or_group | denotes | PR |
| T26 | 880-884 | cell_component | denotes | cell |
| T27 | 885-892 | cell_component | denotes | nucleus |
| T28 | 974-985 | cell_type | denotes | tumor cells |
| T29 | 1032-1049 | other_name | denotes | Pleural effusions |
| T30 | 1058-1066 | multi_cell | denotes | patients |
| T31 | 1072-1085 | other_name | denotes | breast cancer |
| T32 | 1099-1101 | protein_family_or_group | denotes | ER |
| T33 | 1125-1127 | protein_family_or_group | denotes | PR |
| T34 | 1213-1215 | protein_family_or_group | denotes | ER |
| T35 | 1220-1222 | protein_family_or_group | denotes | PR |
| T36 | 1237-1254 | protein_family_or_group | denotes | hormone receptors |
| T37 | 1262-1275 | tissue | denotes | primary tumor |
| T38 | 1294-1296 | protein_family_or_group | denotes | ER |
| T39 | 1306-1308 | protein_family_or_group | denotes | PR |
| T40 | 1310-1318 | multi_cell | denotes | patients |
| T41 | 1461-1472 | cell_type | denotes | tumor cells |
| T42 | 1482-1499 | other_name | denotes | pleural effusions |
| T43 | 1550-1575 | protein_family_or_group | denotes | hormone receptor proteins |
| T44 | 1590-1609 | other_name | denotes | malignant effusions |
| T45 | 1677-1689 | other_name | denotes | primary site |
| T46 | 1693-1699 | other_name | denotes | cancer |